Table 3 Top ranked statistically significant connections of LC28-0126 with reference drug profiles.

From: Drug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma

ATC1

ATC classification

CMAP instance

Concentration

Cell line

Set size

Query length

Score

P value

Standardized score

R03DA01

DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES

Dyphilline

15.8 uM

MCF7

2

24

0.3728

0.00010

4.1185

N07CA01

OTHER NERVOUS SYSTEM DRUGS

Betahistine

17.2 uM

PC3

1

24

0.4484

0.00004

3.8125

G04AB03

UROLOGICALS

Pipemidic Acid

13.2 uM

MCF7

1

24

0.4005

0.00034

3.4050

N/A2

 

5186223

12 uM

MCF7

1

24

0.3914

0.00048

3.3274

C01BC04

CARDIAC THERAPY

Flecainide

8.4 uM

PC3

2

24

0.1995

0.00100

3.2787

C05AA11

VASOPROTECTIVES

Fluocinonide

8 uM

MCF7

3

24

−0.3693

0.00010

−3.9616

R05DB21

COUGH AND COLD PREPARATIONS

Cloperastine

11 uM

MCF7

3

24

−0.2523

0.00020

−3.9635

N/A

 

Sirolimus

0.1 uM

MCF7

2

24

−0.4078

0.00010

−4.0492

C01BC03

CARDIAC THERAPY

Propafenone

10.6 uM

MCF7

2

24

−0.3833

0.00010

−4.0797

A07EA07

ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS

Beclometasone

7.6 uM

MCF7

1

24

−0.4967

0.00001

−4.2229

  1. 1ATC: Anatomical Therapeutic Chemical Classification System.
  2. 2N/A: Not Available.